Wilson Sonsini Goodrich & Rosati has announced that Andrea Linna has joined the firm’s regulatory department as a partner.
Linna will be a part of the firm’s Digital Health industry group and its FDA Regulatory, Healthcare and Consumer Products practice.
She will be based remotely from Chicago and work closely with colleagues and clients across the country.
Doug Clark, managing partner, Wilson Sonsini, said:
“Our interdisciplinary team continues to work with a growing number of sophisticated and successful digital health companies, as well as the investors that finance them.
“As our digital health clients diversify and expand into new markets with new innovations, they seek legal advice in broader areas, including the many regulatory issues that Andrea has focused on for nearly a decade.
“We are excited to have her join our firm.”
Before joining Wilson Sonsini, Linna was a partner at McGuireWoods, where she co-led that firm’s Digital Health, Technology and Innovation practice group.
Over the oast 10 years, Linna focused her practice on healthcare law and amassed substantial experience representing clients in healthcare regulatory matters related to mergers and acquisitions, data privacy and security, and healthcare IT.
Linna’s clients have included healthcare technology start-ups and industry investors, as well as healthcare systems, providers, payers, and facilities with digital health initiatives.
“As a healthcare technology lawyer, I see every day the potential that technology has to revolutionise healthcare.
“I am thrilled to join Wilson Sonsini and collaborate with a team that shares my passion for working with clients at the forefront of technology.
“Together, we offer clients unparalleled support in adapting to the rapidly changing healthcare regulatory landscape and ensuring they remain at the cutting edge of innovation.”
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
Anti-choke mug protects Parkinson’s patients
AI model predicts breast cancer risk without racial bias
TheHill secures UK gov funding and Barclays support to help advance digital innovation
Real time data collection changes the game for the stroke patient pathway
Inside BT’s mission to boost NHS connectivity
- Products4 weeks ago
Pioneering paediatric pressure ulcer mattress to be showcased at MEDICA 2023
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion4 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- Biotech4 weeks ago
LiliumX unveils rebrand as Valink Therapeutics and appointment of new board and execs after securing $7.8m investment